BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CBLB, DKFZp686J10223, 868, ENSG00000114423, Nbla00127, RNF56, FLJ41152, FLJ36865, DKFZp779F1443, DKFZp779A0729 AND Prognosis
24 results:

  • 1. Identification of epithelial-mesenchymal transition-related biomarkers in lung adenocarcinoma using bioinformatics and lab experiments.
    Cheng Y; Shen Y; Fang Q; Duan S; Wang Y; Dai X; Chen Y
    Aging (Albany NY); 2023 Oct; 15(21):11970-11984. PubMed ID: 37910672
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Postoperative circulating tumor DNA detection and cblb mutations are prognostic biomarkers for gastric cancer.
    Zhou H; Liu H; Li J; Wang J; Fu X; Li Y; Mao S; Du J
    Genes Genomics; 2023 Aug; 45(8):1037-1046. PubMed ID: 37306927
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Combined Radiomics-Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell lung cancer.
    Chen W; Wang L; Hou Y; Li L; Chang L; Li Y; Xie K; Qiu L; Mao D; Li W; Xia Y
    Technol Cancer Res Treat; 2022; 21():15330338221142400. PubMed ID: 36476110
    [No Abstract]    [Full Text] [Related]  

  • 4. Diagnostic and Prognostic Nomograms for lung Metastasis in Triple-Negative Breast cancer.
    Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
    Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of TIMELESS and RORA as key clock molecules of non-small cell lung cancer and the comprehensive analysis.
    Xian H; Li Y; Zou B; Chen Y; Yin H; Li X; Pan Y
    BMC Cancer; 2022 Jan; 22(1):107. PubMed ID: 35078435
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
    Metheny L; Callander NS; Hall AC; Zhang MJ; Bo-Subait K; Wang HL; Agrawal V; Al-Homsi AS; Assal A; Bacher U; Beitinjaneh A; Bejanyan N; Bhatt VR; Bredeson C; Byrne M; Cairo M; Cerny J; DeFilipp Z; Perez MAD; Freytes CO; Ganguly S; Grunwald MR; Hashmi S; Hildebrandt GC; Inamoto Y; Kanakry CG; Kharfan-Dabaja MA; Lazarus HM; Lee JW; Nathan S; Nishihori T; Olsson RF; Ringdén O; Rizzieri D; Savani BN; Savoie ML; Seo S; van der Poel M; Verdonck LF; Wagner JL; Yared JA; Hourigan CS; Kebriaei P; Litzow M; Sandmaier BM; Saber W; Weisdorf D; de Lima M
    Transplant Cell Ther; 2021 Nov; 27(11):923.e1-923.e12. PubMed ID: 34428556
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comorbidities and mortality risk among extensive-stage small-cell lung cancer patients in mainland China: impacts of hypertension, type 2 diabetes mellitus, and chronic hepatitis B virus infection.
    Xiu W; Huang Y; Li Y; Yu M; Gong Y
    Anticancer Drugs; 2022 Jan; 33(1):80-90. PubMed ID: 34183497
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database.
    Zhang Z; Zhao X; Li Z; Wu Y; Liu Y; Li Z; Li G
    BMC Cancer; 2021 May; 21(1):567. PubMed ID: 34006241
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
    Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
    [No Abstract]    [Full Text] [Related]  

  • 10. Loss of ATRX expression predicts worse prognosis in pulmonary carcinoid tumors.
    Terra Md SBSP; Xie Md PhD H; Boland Md JM; Mansfield Md AS; Molina Md PhD JR; Roden Md AC
    Hum Pathol; 2019 Dec; 94():78-85. PubMed ID: 31499081
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer.
    Kim CG; Kim KH; Pyo KH; Xin CF; Hong MH; Ahn BC; Kim Y; Choi SJ; Yoon HI; Lee JG; Lee CY; Park SY; Park SH; Cho BC; Shim HS; Shin EC; Kim HR
    Ann Oncol; 2019 Jul; 30(7):1104-1113. PubMed ID: 30977778
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Suppressed expression of Cbl-b by NF-κB mediates icotinib resistance in EGFR-mutant non-small-cell lung cancer.
    Zhang T; Zheng C; Hou K; Wang J; Zhang Y; Fan Y; Zhao H; Qu X; Liu Y; Kang J; Che X; Hu X
    Cell Biol Int; 2019 Feb; 43(2):98-107. PubMed ID: 29972257
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic roles of lymph node micrometastasis in non-small cell lung cancer.
    Jeong JH; Kim NY; Pyo JS
    Pathol Res Pract; 2018 Feb; 214(2):240-244. PubMed ID: 29129492
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Benefits of marriage on relative and conditional relative cancer survival differ between males and females in the USA.
    Merrill RM; Johnson E
    J Cancer Surviv; 2017 Oct; 11(5):578-589. PubMed ID: 28770444
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
    Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
    Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Single Nucleotide Polymorphisms in cblb, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell lung cancer.
    Li P; Wang X; Liu Z; Liu H; Xu T; Wang H; Gomez DR; Nguyen QN; Wang LE; Teng Y; Song Y; Komaki R; Welsh JW; Wei Q; Liao Z
    Clin Lung Cancer; 2016 Jul; 17(4):253-262.e5. PubMed ID: 26732495
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Clinical features and treatment outcome of multiple primary lung cancer patients with different imaging performance].
    Chen K; Wang X; Yang F; Zhao H; Li Y; Liu Y; Zhou Z; Jiang G; Li J; Liu J; Wang J
    Zhonghua Wai Ke Za Zhi; 2015 Oct; 53(10):731-6. PubMed ID: 26654303
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
    Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
    Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MMP7-mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy.
    Hsu TI; Lin SC; Lu PS; Chang WC; Hung CY; Yeh YM; Su WC; Liao PC; Hung JJ
    Oncogene; 2015 Feb; 34(7):826-37. PubMed ID: 24632608
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma.
    Huang J; Song H; Liu B; Yu B; Wang R; Chen L
    J Exp Clin Cancer Res; 2013 Oct; 32(1):84. PubMed ID: 24423157
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.